Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Taste receptor type 1 member 1 + Taste receptor type 1 member 3 (T1R1+T1R3) is a heterodimeric class C G protein-coupled receptor that functions as the primary umami taste receptor in mammals, detecting L-amino acids (especially L-glutamate) and 5'-ribonucleotides such as inosine monophosphate (IMP)[1][2][3]. The receptor is broadly expressed in taste receptor cells of the tongue and is responsible for the perception of savory or "umami" taste, which is a key component of flavor in protein-rich foods. The T1R1 subunit plays a dominant role in determining ligand specificity, with significant species differences: human T1R1+T1R3 is highly selective for L-glutamate (L-Glu), while mouse T1R1+T1R3 responds to a wider range of L-amino acids[1]. The receptor contains a large extracellular ligand-binding domain (LBD) with an orthosteric binding site for intrinsic agonists, and ligand binding induces a conformational change that activates downstream signaling pathways[2][3]. In addition to the orthosteric site, non-orthosteric sites modulate receptor activity and ligand specificity[1]. Synergistic enhancement of receptor response occurs when both amino acids and nucleotides (e.g., IMP) are present, a hallmark of umami taste perception[1][3]. The T1R1+T1R3 receptor is not currently a direct therapeutic target but is of interest for understanding taste biology and potentially for modulating flavor perception in food and nutrition[1][2][3].
Ligand binding induces receptor activation leading to G protein-coupled signal transduction
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Taste receptor type 1 member 1 + Taste receptor type 1 member 3 (T1R1+T1R3).